Caption Management, LLC Zentalis Pharmaceuticals, Inc. Call Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $3.44 Million - $7.05 Million	350,000 New	350,000 $5.3 Million
Q1 2022 May 13, 2022	SELL	$41.58 - $80.89 $1.57 Million - $3.05 Million	-37,700 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$66.92 - $84.79 $1.81 Million - $2.3 Million	-27,100 Reduced 41.82%	37,700 $3.17 Million
Q3 2021 Nov 12, 2021	BUY	$46.83 - $73.5 $1.28 Million - $2.01 Million	27,300 Added 72.8%	64,800 $4.32 Million
Q2 2021 Aug 16, 2021	BUY	$37.41 - $62.25 $1.4 Million - $2.33 Million	37,500 New	37,500 $2 Million

141

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $184M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.